Valeant Pharma (NYSE: VRX) issued the following statement following earlier accusations of fraud by short seller Citron Research, which has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Momentum Movers Short Sales Trader Talk Trading Halts

Valeant Pharma (VRX) Shares Active Ahead of Monday's Conference CallOctober 23, 2015 3:53 PM Deutsche Bank 'Remains Cautious' on Valeant (VRX); Analyst Maintains Hold RatingOctober 22, 2015 9:37 AM Ackman Affirms Buying Another 2M Valeant Pharma (VRX) Shares; Hasn't Sold Any - BloombergOctober 21, 2015 2:58 PM Valeant Pharma (VRX) Pares Decline on Trading ResumptionOctober 21, 2015 1:54 PM